<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H8B9730016F284ADD8B00B312A6CC1D54" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 1563 IH: Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-03-16</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1563</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170316">March 16, 2017</action-date><action-desc><sponsor name-id="K000386">Mr. Katko</sponsor> (for himself, <cosponsor name-id="C001092">Mr. Collins of New York</cosponsor>, <cosponsor name-id="D000625">Mr. Donovan</cosponsor>, <cosponsor name-id="G000559">Mr. Garamendi</cosponsor>, <cosponsor name-id="G000551">Mr. Grijalva</cosponsor>, <cosponsor name-id="J000294">Mr. Jeffries</cosponsor>, <cosponsor name-id="K000210">Mr. King of New York</cosponsor>, <cosponsor name-id="L000563">Mr. Lipinski</cosponsor>, <cosponsor name-id="M001143">Ms. McCollum</cosponsor>, <cosponsor name-id="W000799">Mr. Walz</cosponsor>, <cosponsor name-id="V000081">Ms. Velázquez</cosponsor>, <cosponsor name-id="Z000017">Mr. Zeldin</cosponsor>, <cosponsor name-id="C001078">Mr. Connolly</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="C001105">Mrs. Comstock</cosponsor>, <cosponsor name-id="U000031">Mr. Upton</cosponsor>, <cosponsor name-id="D000604">Mr. Dent</cosponsor>, <cosponsor name-id="R000585">Mr. Reed</cosponsor>, <cosponsor name-id="P000607">Mr. Pocan</cosponsor>, <cosponsor name-id="S001196">Ms. Stefanik</cosponsor>, <cosponsor name-id="S000522">Mr. Smith of New Jersey</cosponsor>, <cosponsor name-id="S001200">Mr. Soto</cosponsor>, and <cosponsor name-id="K000381">Mr. Kilmer</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to provide for the establishment of a mesothelioma patient
			 registry, and for other purposes.</official-title></form>
	<legis-body id="H9BCD508A2EF84FA28276BFD342F1E2F5" style="OLC">
 <section id="H4224663C59B54722A32FC48DA2A54E65" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017</short-title></quote>.</text> </section><section id="HDB271270BFA94079BEB6C853433FDD9C"><enum>2.</enum><header>Patient registry for mesothelioma data collection and research</header><text display-inline="no-display-inline">Title III of the Public Health Service Act is amended by inserting after section 399V–6 of such Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280g-17">42 U.S.C. 280g–17</external-xref>) the following:</text>
			<quoted-block display-inline="no-display-inline" id="HDFDBECD84D1F482FBB0D3994541A056C" style="OLC">
				<section id="HC1E30EE31C884404B73F988DFA213B31"><enum>399V–7.</enum><header>Patient registry for mesothelioma data collection and research</header>
 <subsection id="H24A0183941894A0B9E9F42E64A170B03"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary, acting through the Administrator of the Agency for Toxic Substances and Disease Registry, shall develop a patient registry to collect data on mesothelioma, including information with respect to the incidence and prevalence of the disease in the United States.</text>
 </subsection><subsection id="H11573C44ED2E454F95CF3DD38648EB9E"><enum>(b)</enum><header>Uses</header><text display-inline="yes-display-inline">The Secretary shall use the registry under subsection (a)—</text> <paragraph id="H93A549C45C444A33936EBBFB1D809B43"><enum>(1)</enum><text>to enhance and expand infrastructure and activities for tracking the epidemiology of mesothelioma patients;</text>
 </paragraph><paragraph id="H92C3ED450E7248629B22284F8EB3FFEE"><enum>(2)</enum><text>to collect, consolidate, and report on health information on patients who have been diagnosed with mesothelioma, including with respect to—</text>
 <subparagraph id="H2F1F4EF40F3548D7AF1E1C0978AF8174"><enum>(A)</enum><text>treatment outcomes, including patient longevity; and</text> </subparagraph><subparagraph id="H0505BA6E133941A281CC3538069C9FE3"><enum>(B)</enum><text>the number of patients receiving treatment for mesothelioma disaggregated by hospital;</text>
 </subparagraph></paragraph><paragraph id="HF3043D779547454AA1B7E1F73C6E3DA5"><enum>(3)</enum><text>to better describe the incidence and prevalence of mesothelioma in the United States;</text> </paragraph><paragraph id="H8101D274996140159A65D94FA6FDD4E0"><enum>(4)</enum><text display-inline="yes-display-inline">to facilitate further research on mesothelioma;</text>
 </paragraph><paragraph id="H22231E82F8E8476A971D2C546B6A65DD"><enum>(5)</enum><text>to examine factors, such as environmental and occupational factors, that may be associated with mesothelioma;</text>
 </paragraph><paragraph id="H483867EFB3FB407BA74F37068967157F"><enum>(6)</enum><text>to better outline key demographic factors (such as age, race or ethnicity, gender, and family history) associated with mesothelioma; and</text>
 </paragraph><paragraph id="HB064D8F9EF874C7F9BFF93FD997979F5"><enum>(7)</enum><text>to make the information in such registry, other than individually identifiable information, available to the public to facilitate and enhance research on, and prevention and treatment of, mesothelioma.</text>
 </paragraph></subsection><subsection id="H7A4DC68B9C134A0CB5B567B3767476B3"><enum>(c)</enum><header>Content</header><text>In carrying out this section, the Secretary—</text> <paragraph id="H0B797FB0645049DDAC704FD3669A1B05"><enum>(1)</enum><text>shall provide for the collection and storage of information on the incidence and prevalence of mesothelioma in the United States;</text>
 </paragraph><paragraph id="H923CF5CFA34944F2B57496A107E65CED"><enum>(2)</enum><text>when scientifically possible, shall provide for the collection and storage of other available information on mesothelioma, such as information concerning—</text>
 <subparagraph id="HFDB11B43484545B59ED2F91E63CB6AE7"><enum>(A)</enum><text>demographics and other information associated or possibly associated with mesothelioma, such as age, race, ethnicity, sex, geographic location, and family history;</text>
 </subparagraph><subparagraph id="H3473D83B831F401B948BF6369ADF1B38"><enum>(B)</enum><text>risk factors associated or possibly associated with mesothelioma, including genetic and environmental risk factors; and</text>
 </subparagraph><subparagraph id="HDDEFB6D76C6C4E7EBF05CCC00C07067A"><enum>(C)</enum><text>diagnosis and progression markers; and</text> </subparagraph></paragraph><paragraph id="HADB4B2D1485F4CA9AE4F1BC69C0484CA"><enum>(3)</enum><text>may provide for the collection and storage of information relevant to analysis on mesothelioma, such as information concerning—</text>
 <subparagraph id="H2CCBE3C2262540DDAE24AA038618D46E"><enum>(A)</enum><text>the epidemiology of the disease;</text> </subparagraph><subparagraph id="H7377A072F8D940B49975E9C9707DDDF3"><enum>(B)</enum><text>the natural history of the disease;</text>
 </subparagraph><subparagraph id="H0D202E856F314675BA2B359941B3AD95"><enum>(C)</enum><text>the prevention of the disease;</text> </subparagraph><subparagraph id="H82C53992F8ED4A7F82994B170DD2F0CA"><enum>(D)</enum><text>the detection, management, and treatment approaches for the disease; and</text>
 </subparagraph><subparagraph id="H94C5E42DB6F84C26AB4009FFD95A18F3"><enum>(E)</enum><text>the development of outcomes measures.</text> </subparagraph></paragraph></subsection><subsection id="H0C365A7A59AD47DA8700AEE1DF36304F"><enum>(d)</enum><header>Consultation</header><text>In carrying out this section, the Secretary shall consult with individuals with appropriate expertise, including non-Federal mesothelioma experts including—</text>
 <paragraph id="HD4251A94652C4019AB8C0820B25F651E"><enum>(1)</enum><text>epidemiologists with experience in disease surveillance or registries;</text> </paragraph><paragraph id="H686F693A336542DF8E2371C94C9DB3C9"><enum>(2)</enum><text>representatives of national voluntary associations that focus on mesothelioma or have demonstrated experience in research, care, or patient service for mesothelioma;</text>
 </paragraph><paragraph id="H5BBAD58E8125420AA62A716E54A64233"><enum>(3)</enum><text>health information technology experts or other information management specialists;</text> </paragraph><paragraph id="HBDD41035801442D1BB45204A54096E7E"><enum>(4)</enum><text>clinicians with expertise in mesothelioma; and</text>
 </paragraph><paragraph id="HB8F470941A814D27826E10E5679ADB21"><enum>(5)</enum><text>research scientists with experience conducting translational research or utilizing surveillance systems for scientific research purposes.</text>
 </paragraph></subsection><subsection id="HCCBE044B67714C609AFD2CA7AE00B21D"><enum>(e)</enum><header>Coordination with other Federal agencies</header><text>The Secretary shall make information in and analysis derived from the registry under this section available, as appropriate, to Federal departments and agencies, such as the National Institutes of Health, the Food and Drug Administration, the Centers for Medicare &amp; Medicaid Services, the Agency for Healthcare Research and Quality, the Department of Veterans Affairs, and the Department of Defense.</text>
 </subsection><subsection id="H058BDC19649D48D58D5C2F8534DF0F21"><enum>(f)</enum><header>Public Access</header><text>Subject to subsection (g), the Secretary shall make information in, and analysis derived from, the registry under this section available, as appropriate, to the public, including researchers.</text>
 </subsection><subsection id="HD9650C6DE209499ABCC0072B2EC44545"><enum>(g)</enum><header>Privacy</header><text display-inline="yes-display-inline">The Secretary shall ensure that privacy and security protections applicable to the registry under this section are at least as stringent as the privacy and security protections under HIPAA privacy and security law (as defined in section 3009).</text>
					</subsection><subsection id="H7F9B28F999624DC19B203E94139348C1"><enum>(h)</enum><header>Reports to Congress</header>
 <paragraph id="H4543F55951354DCBA37CE16F034FEC3D"><enum>(1)</enum><header>Initial report</header><text>Not later than 18 months after the date of enactment of the <short-title>Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017</short-title>, the Secretary shall submit to the Congress a report that—</text> <subparagraph id="HF0917C90EAEA4EBAA8704BA1578FA2C9"><enum>(A)</enum><text>shall outline—</text>
 <clause id="HD83B4461BC54499D9E5C8AEDB5744391"><enum>(i)</enum><text>the findings in the mesothelioma patient registry under subsection (a);</text> </clause><clause id="HD114CA759ACB427A937A88EF450C375D"><enum>(ii)</enum><text>future plans for expansion or revision of such registry; and</text>
 </clause><clause id="H0D318ABE6098439BA3985D89E800355F"><enum>(iii)</enum><text>the scope of such registry; and</text> </clause></subparagraph><subparagraph id="H061921E759CC4629B709AE4A10186A71"><enum>(B)</enum><text>may include a description of the activities undertaken by the Secretary to establish partnerships with research and patient advocacy communities to expand such registry.</text>
 </subparagraph></paragraph><paragraph id="H07060CC25C70438B82F7C079BF0F8503"><enum>(2)</enum><header>Subsequent report</header><text>Not later than 4 years after the date of enactment of the <short-title>Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017</short-title>, the Secretary shall submit a report to the Congress concerning the implementation of this section. Such report should include information on—</text>
 <subparagraph id="HED0407FB5A5E4CAAAF4D930C6ECD1FE4"><enum>(A)</enum><text>the development and maintenance of the mesothelioma patient registry under subsection (a);</text> </subparagraph><subparagraph id="H29608F2741584EE7A06E5ACA8CA1750B"><enum>(B)</enum><text>the type of information collected and stored in the registry;</text>
 </subparagraph><subparagraph id="H5B04E3C316AD4DE8B65594D0FF3BA62D"><enum>(C)</enum><text>the use and availability of such information, including guidelines for such use; and</text> </subparagraph><subparagraph id="H7B1F0010E5E647BDA2EBADDC4FDDB0D6"><enum>(D)</enum><text>the use and coordination of databases that collect or maintain information on mesothelioma.</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body></bill>


